Optomed Plc: Interim Report, January – March 2022
Optomed Plc Stock Exchange Release 5 May 2022 at 9.00, Helsinki Optomed Plc: Interim Report, January – March 2022 January – March 2022 · Revenue decreased by 18.5 percent to EUR 3.2 (3.9) million · Devices segment revenue decreased by 26.5 % to EUR 1.1 (1.4) million · Software segment revenue decreased by 13.9 % to EUR 2.2 (2.5) million against the strong comparison period · EBITDA amounted to EUR -937 (-315) thousand corresponding to -29.2 (-8.0) percent of revenue · In the Devices segment, the revenue from China declined over 90% whereas the rest of the